OPKO Health Inc.
OPK | TA
Overview
Corporate Details
- ISIN(s):
- US68375N1037
- LEI:
- Country:
- Israel
- Address:
- 4400 Biscayne Blvd., 33137 Miami
- Website:
- https://www.opko.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Opko Health operates in the healthcare sector, providing diagnostic products, pharmaceuticals, and innovative medical solutions in Israel.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for OPKO Health Inc..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-10 02:28 |
Director's Dealing
Immediate Report
|
English | 51.5 KB | |
| 2025-08-10 02:28 |
Related Party Transaction
Immediate Report
|
English | 36.3 KB | |
| 2025-08-01 01:34 |
Foreign Filer Report
Report of Periodic or Interim Report
|
English | 36.6 KB | |
| 2025-08-01 01:19 |
Quarterly Report
Immediate Report
|
English | 202.1 KB | |
| 2025-08-01 01:19 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | |
| 2025-08-01 01:13 |
Earnings Release
Immediate Report
|
English | 292.7 KB | |
| 2025-08-01 01:13 |
Foreign Filer Report
Immediate Report
|
English | 36.4 KB | |
| 2025-07-26 22:17 |
Report Publication Announcement
Immediate Report
|
English | 162.7 KB | |
| 2025-07-26 22:17 |
Report Publication Announcement
Immediate Report
|
English | 36.4 KB | |
| 2025-07-08 17:09 |
Regulatory News Service
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
|
English | 160.7 KB | |
| 2025-07-08 17:09 |
Foreign Filer Report
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for …
|
English | 36.4 KB | |
| 2025-06-25 18:02 |
Report Publication Announcement
to Participate in the 3rd Annual Piper Sandler Virtual Obesity
Symposium
|
English | 118.5 KB | |
| 2025-06-25 18:02 |
Regulatory News Service
to Participate in the 3rd Annual Piper Sandler Virtual Obesity
Symposium
|
English | 36.4 KB | |
| 2025-06-25 18:00 |
Regulatory News Service
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tabl…
|
English | 193.3 KB | |
| 2025-06-25 18:00 |
Foreign Filer Report
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tabl…
|
English | 36.6 KB |
Automate Your Workflow. Get a real-time feed of all OPKO Health Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OPKO Health Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nortem BioGroup | Spain | MLBIO | |
|
Novo Nordisk | Denmark | NOVO | |
|
NRGene Technologies Ltd. | Israel | NRGN | |
|
NUFORMIX PLC | United Kingdom | NFX | |
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO |